key: cord-0798895-gcup2brr
authors: Baird, Brandon J.; Sung, C. Kwang
title: COVID-19: Challenges associated with the treatment of Head and Neck Oncology and Laryngology Patients in the COVID-19 era
date: 2020-08-22
journal: Otolaryngol Clin North Am
DOI: 10.1016/j.otc.2020.08.004
sha: e4b519774f7c3e60429c49a1a7aed7b8b91f9d20
doc_id: 798895
cord_uid: gcup2brr

This review explores the changes to practice associated with COVID-19 for providers treating patients with head and neck cancer and laryngeal pathology. The aim of the review is to highlight some of the challenges and considerations associated with treating this patient population during the pandemic. Additionally, it seeks to discuss some of the areas of concern related to ramping up clinical volume.

As cases continue to rise, increased emphasis has been placed on protection for the provider in the clinical setting. Over the last decade, office-based management of many common laryngeal disorders has significantly expanded 13 . This includes, but is not limited to, office-based laser ablation of papilloma or dysplasia, transoral or transcervical injection laryngoplasty for vocal fold paralysis, and EMG-guided injection of Botox for spasmodic dysphonia. Given the high number of clinic-based aerosol-generating procedures practiced by today's laryngologists, many providers have seen a marked reduction in their ability to treat patients and their clinical productivity. Within the category of aerosol-generating procedures is flexible fiberoptic laryngoscopy, one of the most widely used diagnostic tools for all otolaryngologists and speech pathologists.

A consensus statement reported by Rameau et al from a virtual webinar attended by approximately 300 participants in the American laryngology community recommended flexible laryngoscopy should be reserved for critical cases in which the findings may have an immediate impact on diagnosis or treatment. "Indications include hemoptysis, odynophagia limiting hydration and nutrition, or airway compromise-notably secondary to infectious and malignant conditions." 14 Some have advocated for pre-clinic COVID testing prior to any aerosol generating procedure 4, 14 , however given the high false negative rate of many available tests the use of universal personal protective precautions is recommended. According to Givi and colleagues, examinations should take place in negative pressure rooms if possible 5 , with avoidance of topical lidocaine spray although other groups recommend administration of a topical anesthetic to theoretically decrease the cough/sneeze reflex (unpublished on-line chats).

A substitute to standard aerosolized anesthesia may be pledgets soaked in 4% lidocaine and J o u r n a l P r e -p r o o f 0.05% oxymetazoline. The group also suggests using videolaryngoscopy whenever possible to keep the practitioner and the patient farther apart. Disposable laryngoscopes should be used whenever possible 5 . Most studies universally recommend the following personal protective equipment (PPE): N95 mask or powered air-purifying respirators (PAPRs), gloves, gown, eye shield (or goggles), and cap 1, 5, 11, 15, 16 . It has also been suggested that the patients wear a mask covering the mouth during flexible laryngoscopy to reduce aerosolization from phonatory maneuvers and in case of coughing or sneezing. At this time, transoral rigid and mirror laryngoscopy are discouraged unless flexible laryngoscopy cannot be performed due to the increased risk of gagging and coughing, as well as the need for the patient to phonate with the mouth uncovered to allow visualization of the larynx. Additionally, universal masking is encouraged in all clinical spaces, in accordance with many state policies. Patients in the waiting rooms are encouraged to physically distance or wait in their car for a phone call prior to presenting for their appointment. Crosby also suggests offering personal protective equipment for the friends and family accompanying the patient during laryngoscopy 17 , and other sites prevent friends and family from accompanying patients inside for the visit. Some alternatives to flexible laryngoscopy have been raised, including transcervical laryngeal ultrasound, which has a reported concordance of 70-95% in identifying vocal fold motion abnormalities 18 .

Another key consideration for the laryngologist in the COVID-19 era is the approach to sanitization and room turnover after aerosol generating procedures (AGPs). Laryngoscope turnover should include high-level disinfection, including the use of such chemical disinfectants as glutaraldehyde, chlorine dioxide, or ortho-phthaladehyde (OPA) 14 . Some authors recommend immediate placement of the scope after use into a covered receptacle for transport from the J o u r n a l P r e -p r o o f examination room to the sterile processing areas 17 . After completion of laryngoscopy, room sanitization with an EPA-registered, hospital-grade disinfectant is recommended with a 2-3% hydrogen peroxide solution, 2-5 g/L chlorine disinfectant, or 75% alcohol 19 . According to the CDC website, it is unknown how long the air inside a particular examination room remains infectious and likely relates to the room size, rapidity of air exchange, patient factors (like viral shedding), amount of coughing/sneezing, and length of time patient was in the room 20 . The CDC suggests that rooms with 50 air changes/hour (ACH) take about 6 and 8 minutes to purify the air with 99% and 99.9% efficiency, respectively. As the number of air changes/hour decreases, the time between patients should be increased to allow for appropriate dissipation of theoretical infectious agents. As such, many hospitals have recommended a turnover time of 4x the time it takes to purify the air with 99% efficiency, which may be either 20 minutes or 40 minutes depending on the level of air turnover, or could be no additional time if any additional HEPA filtration system and negative pressure has been added. Limited data exists to support this approach for SARS-CoV-2.

Laryngology patients are quite diverse with respect to their level of acuity. Some patients require more urgent intervention, while others may have their care deferred 12, 21 . Most guidelines advocate for a tiered approach to ramping up both clinic-based and surgical activity. The American Academy of Otolaryngology published guidelines for ramping up clinical activity on May 15, 2020. The AAO recommends limiting patient care to individuals with "time-sensitiveurgent and emergent medical conditions." 12 This approach is also echoed in the care of head and neck cancer patients (see below). According to the guidelines, emergent conditions include "impending airway obstruction due to infection, neoplasm, stenosis, foreign body", which may J o u r n a l P r e -p r o o f warrant the following intervention: "flexible and rigid laryngoscopy with intervention, direct laryngoscopy/suspension laryngoscopy, bronchoscopy, and tracheostomy". Urgent conditions include "moderate or impending airway obstruction, progressive dysphonia, progressive dysphagia, glottic incompetence causing aspiration or impaired pulmonary toilet", which warrant the previously described procedures in addition to "stroboscopy, functional endoscopic evaluation of swallow, esophagoscopy with or without intervention, open airway procedures for cancer". Time sensitive conditions include "T1 glottic carcinoma or carcinoma in situ, stable/mild dysphonia, stable dysphagia", which adds "transcervical Botox injection" to the above list of procedures. Routine conditions which may be deferred for 90 days or more include "mild/moderate dysplasia, non-obstructive benign/phonotraumatic lesions of the vocal folds, glottic incompetence, glottic incompetence with mild to moderate dysphonia, gender affirmation, globus/cough without alarm signs." Comparing acuity of patients also raises an important point about the subset of patients who are typically seen for benign, phonotraumatic voice disorders.

Many live vocal performance venues have shut down, concerts have been cancelled or postponed, and some studies point to live singing as being a potential source of massive spread [22] [23] [24] . For this reason, one might assume that the percentage of patients being seen for acute phonotraumatic voice disorders diminishes somewhat. Conversely, as patients continue to recover from hospitalizations related to COVID-19, it is anticipated that there may be a number of patients with sequelae of prolonged intubation including posterior glottic stenosis, vocal fold granulomas, and tracheal/subglottic stenosis.

Laryngeal surgery in the era of COVID has had to undergo some significant changes in the approach to patient triage, surgical technique, and management of the airway. Pre-operative Airway management in the COVID-19 era has become a point of focus for quality improvement and safety groups. Endotracheal intubation is cited as one of the procedures which seems to have the highest aerosol generating burden 1,2,5 . It is recommended that intubation be performed by the most experienced practitioner. Additionally, some recommend early intubation for patients that are high risk for decompensation 2 , while others have advocated delaying intubation in favor of non-invasive means of ventilation. This may include high flow nasal cannula, which actually has minimal dispersion of exhaled air if appropriately fitted according to Cheung 2, 29 . It is recommended that flexible fiberoptic intubation be avoided whenever possible 30 Silverman points out that head and neck cancer patients tend to present with advanced age, history of tobacco and alcohol abuse, and cardiac and pulmonary comorbidities, which are similarly found in COVID-19 39 . Risk of respiratory sequelae in patients who have received chemotherapy and/or radiation therapy are high, with increased rates of dysphagia, aspiration, and pneumonia. Additionally, head and neck cancer patients have an increased risk of respiratory infections and aspiration pneumonitis 39 . These factors may expedite deterioration to J o u r n a l P r e -p r o o f severe adverse events in patients with COVID-19. Additionally, head and neck patients who are actively receiving chemotherapy or immunotherapy may have depressed immune function, malnutrition, and older age. For this reason, the patients need to be carefully selected and comorbidities strongly considered when constructing a treatment plan for patients with head and neck cancer.

Within the United States, mortality for patients of color (African American and Latinx) with COVID-19 is significantly higher than for Caucasian patients 40 . Unfortunately, this is a consequence of inequality within society and the healthcare system, rather than a biological or pathological difference. 41 Correspondingly, these communities also tend to present with more advanced disease and have significantly worse mortality compared to their Caucasian fellow citizens. This pandemic has laid to bear some of the gross inequities within the American health care system and highlighted the need for equitable decision making for all patients with a diagnosis of head and neck cancer during the COVID-19 era.

Another consideration for the head and neck cancer patient during the COVID-19 era, may include the financial burden and cost of survivorship associated with undergoing cancer treatment and financial hardship related to COVID-19's effect on the world economy and increasing levels of unemployment 41, 42 . Given the significant job losses across the United States, there is preliminary data to suggest that there will be at least 1.55 million newly unemployed people who will also lose their insurance coverage in the wake of the pandemic 43 .

Increased financial strain has been associated with decreased quality of life scores and subsequently mortality in head and neck cancer patients 44-48 .

Recommendations for head and neck clinic are similar to what was previously discussed for laryngology. Providers are expected to take universal precautions, regardless of the patient's COVID status. Flexible fiberoptic laryngoscopy is considered a high-risk aerosol generating procedure. Due to this, laryngoscopy should be reserved for instances in which it is likely to change management. One of the beneficial consequences of the COVID-19 era is the increased access of care through the widespread adoption of telehealth clinics among most hospitals 49 .

Providers may use telemedicine as an initial pre-operative assessment or pre-screen for patients that will later be seen in clinic or prior to surgery. While telehealth is wonderful for obtaining a detailed history, reviewing data/imaging/labs, and discussing surgical options/risks/benefits, a big drawback is the inability to perform a comprehensive head and neck physical exam 26 .

Physical examination, with or without fiberoptic laryngoscopy, is important to define the extent of tumor and formulating an ablative and reconstructive plan. Fortunately, some work-arounds include anatomic and physiologic imaging for ablative planning and CT angiography and virtual planning sessions for microvascular reconstruction. Telemedicine also serves a vital role in triage of post-treatment head and neck cancer patients who may not be able to be seen as frequently due to the pandemic 5,12 .

Telemedicine also serves a vital role in the coordination of care between multiple oncologic disciplines. Dharmarajan and colleagues highlighted the University of Pittsburgh approach to a virtual multidisciplinary tumor board clinic (MDC). This strategy has been adopted by multiple institutions, and works quite well to coordinate care between specialties. In their study, they found that 57.9% of virtual tumor board participants preferred virtual multidisciplinary clinic to Similarly, the review recommends considering alternatives to long-duration microvascular reconstructive cases. It is recommended that the focus shift to simplifying reconstruction and J o u r n a l P r e -p r o o f reducing surgical duration, when it's feasible and appropriate. However, it is also acknowledged that this approach may lead to an increase in downstream complications. Endocrine surgery is similarly tiered in a memo by Ashok Shaha, which outlines a strategic approach to thyroid surgery during the pandemic. Similar to other strategies, anaplastic thyroid cancer, medullary thyroid cancer, and locally aggressive differentiated thyroid cancer, specifically with impending concern for airway obstruction take precedent 50 . However, some alternatives are also discussed, for instance, in patients with BRAF V600E mutations, who may have surgery delayed while being treated with appropriate targeted therapies. Additionally, de-escalation of surgical care is advocated for benign conditions like thyroid goiters that are non-obstructive, and even papillary thyroid microcarcinoma (which may be followed with serial ultrasonography until resource allocation has returned to pre-COVID levels).

As institutions attempt to weigh the pros and cons of elective and essential surgery in the midst of the pandemic, some authors have advocated for creating rating systems to allow for appropriate surgical triage during periods of limited clinical output and resource re-allocation.

The medically necessary, time-sensitive (MeNTS) procedures scoring system aims to "ethically and efficiently manage resource re-allocation and risk to healthcare providers" during the COVID-19 pandemic 51 . The scoring system, which uses procedural, disease, and patient factors within a 5-point Likert scale to determine the potential risk of proceeding with surgery. The cumulative MeNTS score may range between 21 and 105, with score above 64 being considered within the high risk or resource heavy procedures, either due to patient factors (Age/Comorbidities) or procedure factors (head and neck surgical site, high anticipated blood loss, ICU admission requirement.). Using scoring systems like MeNTS should help hospitals more J o u r n a l P r e -p r o o f appropriately and objectively triage elective and essential surgeries in the setting of a resurgence of cases/limiting of resources.

Given the significant lack of available knowledge regarding SARS-CoV2 and its associated complications, it is difficult to characterize risk for patients undergoing ablative and reconstructive head and neck surgery. As mentioned earlier, in asymptomatic COVID-19 positive patients undergoing elective surgery, mortality approached 20% 25 . COVID-19 has demonstrated myriad manifestations which might interfere with the success and management of patients undergoing head and neck surgery. Tang demonstrated that coagulopathy was more common in patients with severe disease, and non-surviving COVID patients 52 . In this study, Ddimer, fibrin degradation products, prothrombin time, and partial thromboplastin time were all significantly increased in non-surviving patients relative to those surviving COVID-19 53 .

Additional studies demonstrate a prothrombotic state in certain patients, with 7 of 12 patients having deep venous thromboses on autopsy 54 . The mechanisms of this COVID-related coagulopathy are not yet well-described in the literature; however, these undefined entities pose certain risk for reconstructive efforts in patients with head and neck cancer.

In lieu of significant surgical delays, radiation +/-chemotherapy may be considered for certain patients. However, administration of chemotherapy and fractionated radiotherapy requires multiple trips to hospitals 55 . This can potentially expose patients, who are already considered high risk, to SARS-CoV2. Sharma and colleagues stress the importance of making informed decisions, weighing not only the patient, comorbidities, and disease status, but also the J o u r n a l P r e -p r o o f prevalence of COVID and resource availability when making decisions about preferred options for treatment.

COVID-19 has forever changed the way that otolaryngologists approach laryngology and head and neck cancer care. Telemedicine has become an effective tool for the work up of disease and interface with patients remotely. Flexible laryngoscopy should be reserved for urgent/timesensitive cases, in which it will have a direct impact on management. Attempts should be made by all providers to ensure that appropriate personal protective equipment is worn and that universal precautions are taken for every patient, regardless of COVID-19 status. Given the high false negative rate associated with nasopharyngeal RT-PCR, the role of pre-clinical or preoperative COVID testing has yet to be rigorously evaluated. Given the high mortality associated with elective surgery in asymptomatic COVID-19 patients, however, pre-operative COVID testing is the best available option for triage of asymptomatic patients. Surgical decisions making should involve both the provider and the patient in a discussion about the necessity of surgery and other alternatives available in the context of the local COVID-19 landscape. Specific tools, like the MeNTS score, may be helpful to risk stratify these patients and inform these decisions.

J o u r n a l P r e -p r o o f

COVID-19 and the Otolaryngologist: Preliminary Evidence-Based Review

Staff safety during emergency airway management for COVID-19 in Hong Kong

COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy

Overview of COVID-19 testing and implications for otolaryngologists

Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic

COVID-19 CORONAVIRUS PANDEMIC

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Head and neck cancer: high-risk population for COVID-19

Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic

Guidance for Return to Practice for Otolaryngology-Head and Neck Surgery Part Two

American Academy of Otolaryngology Head and Neck Surgery

Office-Based 532-Nanometer Pulsed Potassium-Titanyl-Phosphate Laser Procedures in Laryngology

Flexible Laryngoscopy and COVID-19

Bronchoscopy, laryngoscopy, and esophagoscopy during the COVID-19 pandemic. Head Neck

Guidance for ENT during the COVID-19 pandemic

Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic

Laryngeal Evaluation during the COVID-19 Pandemic: Transcervical Laryngeal Ultrasonography

Perioperative management strategy of severe traumatic brain injury during the outbreak of COVID-19

Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic

Otolaryngologists and the Doctor-Patient Relationship during a Pandemic

Aerosol emission and superemission during human speech increase with voice loudness

When Will It Be Safe to Sing Together Again?

But Isolation Helped Contain It

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach

Head and neck cancer care in the COVID-19 pandemic: A brief update

The impact of preoperative screening system on head and neck cancer surgery during the COVID-19 pandemic: Recommendations from the nationwide survey in Japan

Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience

Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19. Head Neck

Sustaining Otolaryngology Services for the Long Haul during the COVID-19 Pandemic: Experience from a Tertiary Health System

A Surgical Safety Checklist for Performing Tracheotomy in Patients with Coronavirus Disease 19

Tracheostomy during SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck Society

Pediatric Microlaryngoscopy and Bronchoscopy in the COVID-19 Era

Lifesaving cancer surgeries need to be managed appropriately during the COVID-19 pandemic

COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis

Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era

COVID-19 and the Widening Gap in Health Inequity

Determinants of racial differences in survival for sinonasal cancer

Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States

Potential impact of the COVID-19 pandemic

Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors

Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer

Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer

Thyroid surgery during COVID-19 pandemic: Principles and philosophies

Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic